intranasal oxytocin spray

DRUG7 trials

Sponsors

University of North Carolina, Chapel Hill, University of Florida, Norwegian University of Science and Technology

Conditions

Alcohol DependenceAlcohol WithdrawalAlcoholismInflammationOpioid DependenceOpioid WithdrawalSchizoaffective DisorderSchizophrenia

Phase 1

Oxytocin Treatment of Alcohol Withdrawal

CompletedNCT01212185

University of North Carolina, Chapel HillAlcohol Withdrawal

Start: 2010-07-31End: 2011-03-31Updated: 2014-05-13

Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia

CompletedNCT01394471

University of North Carolina, Chapel HillSchizoaffective Disorder, Schizophrenia

Start: 2011-07-31End: 2015-01-31Updated: 2015-06-11

Oxytocin Aging Study

TerminatedNCT02069431

University of FloridaInflammation

Start: 2016-02-29End: 2020-05-31Updated: 2020-06-19

Oxytocin Treatment of Opioid Dependence

CompletedNCT02548728

University of North Carolina, Chapel HillOpioid Dependence, Opioid Withdrawal

Start: 2016-02-29End: 2016-12-31Updated: 2019-08-07

Phase 2

Oxytocin Treatment of Alcohol Dependence

CompletedNCT02275611

University of North Carolina, Chapel HillAlcohol Dependence, Alcohol Withdrawal

Start: 2013-01-31End: 2014-03-31Updated: 2017-04-04

Phase 3

Oxytocin and Alcohol Withdrawal and Dependence

CompletedNCT02903251

Norwegian University of Science and TechnologyAlcoholism, Substance-Related Disorders

Start: 2016-10-31End: 2018-01-22Updated: 2019-02-26

Intranasal Oxytocin Effects in Alcohol Withdrawal and Dependence; Follow-up Study

CompletedNCT03339024

Norwegian University of Science and TechnologyAlcoholism, Substance-Related Disorders

Start: 2017-11-01End: 2019-03-31Updated: 2020-02-19